Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alvin Ezra Davis III, M.D.

Title
Institution
Department
Address

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R01AI057366 (DAVIS, ALVIN E) Feb 1, 2005 - Jan 31, 2010
    NIH
    C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
    Role: Principal Investigator
  2. P60AR044059 (GLASS, DAVID N.) Jul 1, 1996 - May 31, 2003
    NIH/NIAMS
    MAMDC--UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE
    Role: Co-Principal Investigator
  3. R01HD033727 (DAVIS, ALVIN E) Feb 1, 1996 - Jul 31, 2006
    NIH
    REGULATION OF C1 INHIBITOR SYNTHESIS
    Role: Principal Investigator
  4. S10RR004003 (DAVIS, ALVIN E) Jun 27, 1988 - Jun 26, 1989
    NIH
    APPLIED BIOSYSTEMS MODEL 420A-03 DERIVATIZER-ANALYZER
    Role: Principal Investigator
  5. R37HD022082 (DAVIS, ALVIN E) Apr 1, 1987 - Apr 30, 2010
    NIH
    C1 INHIBITOR GENE AND HEREDITARY ANGIONEUROTIC EDEMA
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Mejia P, Diez-Silva M, Kamena F, Lu F, Fernandes SM, Seeberger PH, Davis AE, Mitchell JR. Human C1-Inhibitor Suppresses Malaria Parasite Invasion and Cytoadhesion via Binding to Parasite Glycosylphosphatidylinositol and Host Cell Receptors. J Infect Dis. 2016 Jan 01; 213(1):80-9. PMID: 26347576; PMCID: PMC4676549.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  2. Mejia P, Davis AE. C1 inhibitor suppresses the endotoxic activity of a wide range of lipopolysaccharides and interacts with live gram-negative bacteria. Shock. 2012 Aug; 38(2):220-5. PMID: 22576004.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  3. Lu F, Fernandes SM, Davis AE. The effect of C1 inhibitor on myocardial ischemia and reperfusion injury. Cardiovasc Pathol. 2013 Jan-Feb; 22(1):75-80. PMID: 22705194.
    Citations: 19     Fields:    Translation:Animals
  4. Davis AE, Lu F, Mejia P. C1 inhibitor, a multi-functional serine protease inhibitor. Thromb Haemost. 2010 Nov; 104(5):886-93. PMID: 20806108.
    Citations: 68     Fields:    Translation:HumansAnimalsCells
  5. Lu F, Fernandes SM, Davis AE. The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol. 2010 Jun; 298(6):G878-83. PMID: 20338925.
    Citations: 16     Fields:    Translation:Animals
  6. Lu F, Chauhan AK, Fernandes SM, Walsh MT, Wagner DD, Davis AE. The effect of C1 inhibitor on intestinal ischemia and reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 2008 Nov; 295(5):G1042-9. PMID: 18787060.
    Citations: 10     Fields:    Translation:AnimalsCells
  7. Davis AE, Mejia P, Lu F. Biological activities of C1 inhibitor. Mol Immunol. 2008 Oct; 45(16):4057-63. PMID: 18674818.
    Citations: 90     Fields:    Translation:HumansAnimalsCells
  8. Davis AE. New treatments addressing the pathophysiology of hereditary angioedema. Clin Mol Allergy. 2008 Apr 14; 6:2. PMID: 18410689.
    Citations: 7     
  9. Davis AE. Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema. Ann Allergy Asthma Immunol. 2008 Jan; 100(1 Suppl 2):S7-12. PMID: 18220146.
    Citations: 19     Fields:    Translation:HumansAnimals
  10. Liu D, Lu F, Qin G, Fernandes SM, Li J, Davis AE. C1 inhibitor-mediated protection from sepsis. J Immunol. 2007 Sep 15; 179(6):3966-72. PMID: 17785834.
    Citations: 17     Fields:    Translation:AnimalsCells
  11. Davis AE, Cai S, Liu D. C1 inhibitor: biologic activities that are independent of protease inhibition. Immunobiology. 2007; 212(4-5):313-23. PMID: 17544816.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  12. Davis AE. Mechanism of angioedema in first complement component inhibitor deficiency. Immunol Allergy Clin North Am. 2006 Nov; 26(4):633-51. PMID: 17085282.
    Citations: 20     Fields:    Translation:HumansAnimals
  13. Liu D, Cramer CC, Scafidi J, Davis AE. N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A. Infect Immun. 2005 Aug; 73(8):4478-87. PMID: 16040958; PMCID: PMC1201182.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  14. Cai S, Dole VS, Bergmeier W, Scafidi J, Feng H, Wagner DD, Davis AE. A direct role for C1 inhibitor in regulation of leukocyte adhesion. J Immunol. 2005 May 15; 174(10):6462-6. PMID: 15879149.
    Citations: 23     Fields:    Translation:HumansAnimalsCells
  15. Rosen FS, Davis AE. Deficiencies of C1 inhibitor. Best Pract Res Clin Gastroenterol. 2005 Apr; 19(2):251-61. PMID: 15833691.
    Citations: 2     Fields:    Translation:Humans
  16. Davis AE. The pathophysiology of hereditary angioedema. Clin Immunol. 2005 Jan; 114(1):3-9. PMID: 15596403.
    Citations: 43     Fields:    Translation:HumansAnimals
  17. Liu D, Zhang D, Scafidi J, Wu X, Cramer CC, Davis AE. C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability. Blood. 2005 Mar 15; 105(6):2350-5. PMID: 15522962.
    Citations: 15     Fields:    Translation:HumansAnimalsCells
  18. Bowen T, Cicardi M, Farkas H, Bork K, Kreuz W, Zingale L, Varga L, Martinez-Saguer I, Aygören-Pürsün E, Binkley K, Zuraw B, Davis A, Hebert J, Ritchie B, Burnham J, Castaldo A, Menendez A, Nagy I, Harmat G, Bucher C, Lacuesta G, Issekutz A, Warrington R, Yang W, Dean J, Kanani A, Stark D, McCusker C, Wagner E, Rivard GE, Leith E, Tsai E, MacSween M, Lyanga J, Serushago B, Leznoff A, Waserman S, de Serres J. Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. J Allergy Clin Immunol. 2004 Sep; 114(3):629-37. PMID: 15356569.
    Citations: 32     Fields:    Translation:Humans
  19. Davis AE. Biological effects of C1 inhibitor. Drug News Perspect. 2004 Sep; 17(7):439-46. PMID: 15514703.
    Citations: 35     Fields:    Translation:HumansAnimals
  20. Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, De Carolis C, Drouet C, Duponchel C, Farkas H, Fáy K, Fekete B, Fischer B, Fontana L, Füst G, Giacomelli R, Gröner A, Hack CE, Harmat G, Jakenfelds J, Juers M, Kalmár L, Kaposi PN, Karádi I, Kitzinger A, Kollár T, Kreuz W, Lakatos P, Longhurst HJ, Lopez-Trascasa M, Martinez-Saguer I, Monnier N, Nagy I, Németh E, Nielsen EW, Nuijens JH, O'grady C, Pappalardo E, Penna V, Perricone C, Perricone R, Rauch U, Roche O, Rusicke E, Späth PJ, Szendei G, Takács E, Tordai A, Truedsson L, Varga L, Visy B, Williams K, Zanichelli A, Zingale L. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004 Sep; 114(3 Suppl):S51-131. PMID: 15356535; PMCID: PMC7119155.
    Citations: 145     Fields:    Translation:Humans
  21. Liu D, Gu X, Scafidi J, Davis AE. N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice. Infect Immun. 2004 Apr; 72(4):1946-55. PMID: 15039314.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  22. Davis AE, Cai S, Liu D. The biological role of the C1 inhibitor in regulation of vascular permeability and modulation of inflammation. Adv Immunol. 2004; 82:331-63. PMID: 14975261.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  23. Davis AE. The pathogenesis of hereditary angioedema. Transfus Apher Sci. 2003 Dec; 29(3):195-203. PMID: 14572810.
    Citations: 9     Fields:    Translation:HumansAnimals
  24. Binkley KE, Davis AE. Estrogen-dependent inherited angioedema. Transfus Apher Sci. 2003 Dec; 29(3):215-9. PMID: 14572812.
    Citations: 7     Fields:    Translation:Humans
  25. Cai S, Davis AE. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J Immunol. 2003 Nov 01; 171(9):4786-91. PMID: 14568956.
    Citations: 28     Fields:    Translation:HumansAnimalsCells
  26. Han Lee ED, Pappalardo E, Scafidi J, Davis AE. Approaches toward reversal of increased vascular permeability in C1 inhibitor deficient mice. Immunol Lett. 2003 Oct 31; 89(2-3):155-60. PMID: 14556973.
    Citations: 6     Fields:    Translation:Animals
  27. Liu D, Cai S, Gu X, Scafidi J, Wu X, Davis AE. C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide. J Immunol. 2003 Sep 01; 171(5):2594-601. PMID: 12928411.
    Citations: 20     Fields:    Translation:AnimalsCells
  28. Liu D, Scafidi J, Prada AE, Zahedi K, Davis AE. Nuclear phosphatases and the proteasome in suppression of STAT1 activity in hepatocytes. Biochem Biophys Res Commun. 2002 Dec 13; 299(4):574-80. PMID: 12459177.
    Citations: 10     Fields:    Translation:HumansCells
  29. Welch TR, Frenzke M, Witte D, Davis AE. C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis. Clin Exp Immunol. 2002 Oct; 130(1):43-8. PMID: 12296852; PMCID: PMC1906496.
    Citations: 12     Fields:    Translation:AnimalsCells
  30. Zahedi K, Prada AE, Mulligan A, Prada JA, Davis AE. Normal transcription of the C1 inhibitor gene is dependent upon a polypurine-polypyrimidine region within the promoter. Inflammation. 2002 Aug; 26(4):183-91. PMID: 12184632.
    Citations:    Fields:    Translation:HumansCells
  31. Han ED, MacFarlane RC, Mulligan AN, Scafidi J, Davis AE. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest. 2002 Apr; 109(8):1057-63. PMID: 11956243; PMCID: PMC150945.
    Citations: 91     Fields:    Translation:HumansAnimals
  32. Zahedi R, MacFarlane RC, Wisnieski JJ, Davis AE. C1 inhibitor: analysis of the role of amino acid residues within the reactive center loop in target protease recognition. J Immunol. 2001 Aug 01; 167(3):1500-6. PMID: 11466370.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  33. Zahedi R, Braun M, Wetsel RA, Ault BH, Khan A, Welch TR, Frenzke M, Davis AE. The C5a receptor is expressed by human renal proximal tubular epithelial cells. Clin Exp Immunol. 2000 Aug; 121(2):226-33. PMID: 10931135; PMCID: PMC1905711.
    Citations: 19     Fields:    Translation:HumansCells
  34. Zahedi K, Bissler JJ, Prada AE, Prada JA, Davis AE. The promoter of the C1 inhibitor gene contains a polypurine.polypyrimidine segment that enhances transcriptional activity. J Immunol. 1999 Jun 15; 162(12):7249-55. PMID: 10358172.
    Citations: 2     Fields:    Translation:HumansCells
  35. Braun M, Davis AE. Cultured human glomerular mesangial cells express the C5a receptor. Kidney Int. 1998 Nov; 54(5):1542-9. PMID: 9844130.
    Citations: 9     Fields:    Translation:HumansCells
  36. Prada AE, Zahedi K, Davis AE. Regulation of C1 inhibitor synthesis. Immunobiology. 1998 Aug; 199(2):377-88. PMID: 9777421.
    Citations: 21     Fields:    Translation:HumansCells
  37. Zahedi K, Prada AE, Prada JA, Davis AE. Characterization of the IFN-gamma-responsive element in the 5' flanking region of the C1 inhibitor gene. J Immunol. 1997 Dec 15; 159(12):6091-6. PMID: 9550409.
    Citations: 2     Fields:    Translation:HumansCells
  38. Zahedi R, Wisnieski J, Davis AE. Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases. J Immunol. 1997 Jul 15; 159(2):983-8. PMID: 9218620.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  39. Bissler JJ, Aulak KS, Donaldson VH, Rosen FS, Cicardi M, Harrison RA, Davis AE. Molecular defects in hereditary angioneurotic edema. Proc Assoc Am Physicians. 1997 Mar; 109(2):164-73. PMID: 9069585.
    Citations: 9     Fields:    Translation:HumansCells
  40. Davis AE. C1 inhibitor. Functional analysis of naturally-occurring mutant proteins. Adv Exp Med Biol. 1997; 425:185-94. PMID: 9433501.
    Citations: 1     Fields:    Translation:HumansCells
  41. Donaldson VH, Bissler JJ, Welch TR, Burton MF, Davis AE. Antibody to C1-inhibitor in a patient receiving C1-inhibitor infusions for treatment of hereditary angioneurotic edema with systemic lupus erythematosus reacts with a normal allotype of residue 458 of C1-inhibitor. J Lab Clin Med. 1996 Oct; 128(4):438-43. PMID: 8833894.
    Citations: 1     Fields:    Translation:Humans
  42. Zahedi R, Aulak KS, Eldering E, Davis AE. Characterization of C1 inhibitor-Ta. A dysfunctional C1INH with deletion of lysine 251. J Biol Chem. 1996 Sep 27; 271(39):24307-12. PMID: 8798678.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  43. Malek R, Aulak KS, Davis AE. The catabolism of intact, reactive centre-cleaved and proteinase-complexed C1 inhibitor in the guinea pig. Clin Exp Immunol. 1996 Jul; 105(1):191-7. PMID: 8697630; PMCID: PMC2200472.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  44. Ernst SC, Circolo A, Davis AE, Gheesling-Mullis K, Fliesler M, Strunk RC. Impaired production of both normal and mutant C1 inhibitor proteins in type I hereditary angioedema with a duplication in exon 8. J Immunol. 1996 Jul 01; 157(1):405-10. PMID: 8683145.
    Citations: 6     Fields:    Translation:HumansCells
  45. Donaldson VH, Wagner CJ, Davis AE. An autoantibody to C1-inhibitor recognizes the reactive center of the inhibitor. J Lab Clin Med. 1996 Feb; 127(2):229-32. PMID: 8636653.
    Citations: 3     Fields:    Translation:HumansCells
  46. Zahedi R, Bissler JJ, Davis AE, Andreadis C, Wisnieski JJ. Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein. J Clin Invest. 1995 Mar; 95(3):1299-305. PMID: 7883978; PMCID: PMC441469.
    Citations: 9     Fields:    Translation:HumansCells
  47. Schurman SJ, McAdams AJ, Beischel L, Davis AE, Welch TR. C3-independent glomerulonephritis in guinea pigs: dependence upon primary humoral response. Clin Immunol Immunopathol. 1995 Jan; 74(1):51-8. PMID: 7994927.
    Citations: 1     Fields:    Translation:Animals
  48. Coutinho M, Aulak KS, Davis AE. Functional analysis of the serpin domain of C1 inhibitor. J Immunol. 1994 Oct 15; 153(8):3648-54. PMID: 7930585.
    Citations: 10     Fields:    Translation:HumansCells
  49. Bissler JJ, Cicardi M, Donaldson VH, Gatenby PA, Rosen FS, Sheffer AL, Davis AE. A cluster of mutations within a short triplet repeat in the C1 inhibitor gene. Proc Natl Acad Sci U S A. 1994 Sep 27; 91(20):9622-5. PMID: 7937817; PMCID: PMC44865.
    Citations: 9     Fields:    Translation:HumansCells
  50. Mandle R, Baron C, Roux E, Sundel R, Gelfand J, Aulak K, Davis AE, Rosen FS, Bing DH. Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor. J Immunol. 1994 May 01; 152(9):4680-5. PMID: 7512602.
    Citations: 10     Fields:    Translation:HumansCells
  51. Zahedi K, Prada AE, Davis AE. Transcriptional regulation of the C1 inhibitor gene by gamma-interferon. J Biol Chem. 1994 Apr 01; 269(13):9669-74. PMID: 8144555.
    Citations: 7     Fields:    Translation:HumansCells
  52. Bissler JJ, Donaldson VH, Davis AE. Contiguous deletion and duplication mutations resulting in type 1 hereditary angioneurotic edema. Hum Genet. 1994 Mar; 93(3):265-9. PMID: 8125476.
    Citations: 7     Fields:    Translation:HumansCells
  53. Shoemaker LR, Schurman SJ, Donaldson VH, Davis AE. Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities. Clin Exp Immunol. 1994 Jan; 95(1):22-8. PMID: 8287604; PMCID: PMC1534616.
    Citations: 19     Fields:    Translation:HumansAnimalsCells
  54. Zahedi K, Prada AE, Davis AE. Structure and regulation of the C1 inhibitor gene. Behring Inst Mitt. 1993 Dec; (93):115-9. PMID: 8172557.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  55. Davis AE, Bissler JJ, Cicardi M. Mutations in the C1 inhibitor gene that result in hereditary angioneurotic edema. Behring Inst Mitt. 1993 Dec; (93):313-20. PMID: 8172583.
    Citations: 1     Fields:    Translation:HumansCells
  56. Aulak KS, Donaldson VH, Coutinho M, Davis AE. C1-inhibitor: structure/function and biologic role. Behring Inst Mitt. 1993 Dec; (93):204-13. PMID: 8172569.
    Citations: 1     Fields:    Translation:HumansCells
  57. Aulak KS, Eldering E, Hack CE, Lubbers YP, Harrison RA, Mast A, Cicardi M, Davis AE. A hinge region mutation in C1-inhibitor (Ala436-->Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. J Biol Chem. 1993 Aug 25; 268(24):18088-94. PMID: 8349686.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  58. Aulak KS, Davis AE, Donaldson VH, Harrison RA. Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers. Protein Sci. 1993 May; 2(5):727-32. PMID: 8495195; PMCID: PMC2142501.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  59. Davis AE, Aulak KS, Zahedi K, Bissler JJ, Harrison RA. C1 inhibitor. Methods Enzymol. 1993; 223:97-120. PMID: 8271970.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  60. Coutinho M, Zahedi K, Whitehead AS, Davis AE. C5 deficiency in A/J mice is not associated with resistance to the development of secondary amyloidosis. Eur J Immunogenet. 1992 Dec; 19(6):419-23. PMID: 1477093.
    Citations:    Fields:    Translation:Animals
  61. Davis AE, Patterson F, Crouch R. The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model. Br J Cancer. 1992 Nov; 66(5):777-80. PMID: 1358165; PMCID: PMC1977962.
    Citations: 3     Fields:    Translation:Animals
  62. Davis AE, Aulak K, Parad RB, Stecklein HP, Eldering E, Hack CE, Kramer J, Strunk RC, Bissler J, Rosen FS. C1 inhibitor hinge region mutations produce dysfunction by different mechanisms. Nat Genet. 1992 Aug; 1(5):354-8. PMID: 1363816.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  63. Frangi D, Aulak KS, Cicardi M, Harrison RA, Davis AE. A dysfunctional C1 inhibitor protein with a new reactive center mutation (Arg-444-->Leu). FEBS Lett. 1992 Apr 13; 301(1):34-6. PMID: 1451784.
    Citations: 7     Fields:    Translation:HumansCells
  64. Shohet JM, Bergamaschini L, Davis AE, Carroll MC. Localization of the human complement component C3 binding site on the IgG heavy chain. J Biol Chem. 1991 Oct 05; 266(28):18520-4. PMID: 1917974.
    Citations: 5     Fields:    Translation:HumansCells
  65. Frangi D, Cicardi M, Sica A, Colotta F, Agostoni A, Davis AE. Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema. J Clin Invest. 1991 Sep; 88(3):755-9. PMID: 1885769; PMCID: PMC295456.
    Citations: 5     Fields:    Translation:HumansCells
  66. Kramer J, Katz Y, Rosen FS, Davis AE, Strunk RC. Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema. J Clin Invest. 1991 May; 87(5):1614-20. PMID: 1902490; PMCID: PMC295244.
    Citations: 7     Fields:    Translation:HumansCells
  67. Ariga T, Carter PE, Davis AE. Recombinations between Alu repeat sequences that result in partial deletions within the C1 inhibitor gene. Genomics. 1990 Dec; 8(4):607-13. PMID: 2276734.
    Citations: 9     Fields:    Translation:HumansCells
  68. Parad RB, Kramer J, Strunk RC, Rosen FS, Davis AE. Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site. Proc Natl Acad Sci U S A. 1990 Sep; 87(17):6786-90. PMID: 2118657; PMCID: PMC54622.
    Citations: 12     Fields:    Translation:HumansCells
  69. Levy NJ, Ramesh N, Cicardi M, Harrison RA, Davis AE. Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene. Proc Natl Acad Sci U S A. 1990 Jan; 87(1):265-8. PMID: 2296585; PMCID: PMC53243.
    Citations: 9     Fields:    Translation:HumansCells
  70. Davis AE. Structure and function of C1 inhibitor. Behring Inst Mitt. 1989 Jul; (84):142-50. PMID: 2679529.
    Citations: 4     Fields:    Translation:HumansCells
  71. Ariga T, Igarashi T, Ramesh N, Parad R, Cicardi M, Davis AE. Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon. J Clin Invest. 1989 Jun; 83(6):1888-93. PMID: 2723063; PMCID: PMC303909.
    Citations: 8     Fields:    Translation:HumansCells
  72. Shelley CS, Remold-O'Donnell E, Davis AE, Bruns GA, Rosen FS, Carroll MC, Whitehead AS. Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proc Natl Acad Sci U S A. 1989 Apr; 86(8):2819-23. PMID: 2784859.
    Citations: 34     Fields:    Translation:HumansAnimalsCells
  73. Cholin S, Gerard NP, Strang CJ, Davis AE. Biologic activity of a C2-derived peptide. Demonstration of a specific interaction with guinea pig lung tissues. J Immunol. 1989 Apr 01; 142(7):2401-4. PMID: 2926138.
    Citations: 1     Fields:    Translation:AnimalsCells
  74. Kirchhausen T, Nathanson KL, Matsui W, Vaisberg A, Chow EP, Burne C, Keen JH, Davis AE. Structural and functional division into two domains of the large (100- to 115-kDa) chains of the clathrin-associated protein complex AP-2. Proc Natl Acad Sci U S A. 1989 Apr; 86(8):2612-6. PMID: 2495531; PMCID: PMC286967.
    Citations: 45     Fields:    Translation:AnimalsCells
  75. Davis AE. Hereditary and acquired deficiencies of C1 inhibitor. Immunodefic Rev. 1989; 1(3):207-26. PMID: 2698641.
    Citations: 3     Fields:    Translation:Humans
  76. Strang CJ, Cholin S, Spragg J, Davis AE, Schneeberger EE, Donaldson VH, Rosen FS. Angioedema induced by a peptide derived from complement component C2. J Exp Med. 1988 Nov 01; 168(5):1685-98. PMID: 2972793; PMCID: PMC2189099.
    Citations: 12     Fields:    Translation:HumansCells
  77. Cicardi M, Igarashi T, Kim MS, Frangi D, Agostoni A, Davis AE. Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema. J Clin Invest. 1987 Dec; 80(6):1640-3. PMID: 2890659; PMCID: PMC442434.
    Citations: 10     Fields:    Translation:Humans
  78. Cicardi M, Igarashi T, Rosen FS, Davis AE. Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema. J Clin Invest. 1987 Mar; 79(3):698-702. PMID: 3818946; PMCID: PMC424179.
    Citations: 16     Fields:    Translation:HumansCells
  79. Remold-O'Donnell E, Davis AE, Kenney D, Bhaskar KR, Rosen FS. Purification and chemical composition of gpL115, the human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Biol Chem. 1986 Jun 05; 261(16):7526-30. PMID: 3711098.
    Citations: 20     Fields:    Translation:HumansAnimalsCells
  80. Davis AE, Whitehead AS, Harrison RA, Dauphinais A, Bruns GA, Cicardi M, Rosen FS. Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11. Proc Natl Acad Sci U S A. 1986 May; 83(10):3161-5. PMID: 3458172; PMCID: PMC323472.
    Citations: 25     Fields:    Translation:HumansCells
  81. Davis AE, Zalut C, Rosen FS, Alper CA. Human factor D of the alternative complement pathway. Physicochemical characteristics and N-terminal amino acid sequence. Biochemistry. 1979 Nov 13; 18(23):5082-7. PMID: 497171.
    Citations: 5     Fields:    Translation:HumansCells
  82. Davis AE, Gelfand EW, Schur PH, Rosen FS, Alper CA. IgG subclass studies of C3 nephritic factor. Clin Immunol Immunopathol. 1978 Sep; 11(1):98-101. PMID: 699392.
    Citations: 1     Fields:    Translation:HumansCells
  83. Davis AE, Davis JS, Rabson AR, Osofsky SG, Colten HR, Rosen FS, Alper CA. Homozygous C3 deficiency: detection of C3 by radioimmunoassay. Clin Immunol Immunopathol. 1977 Nov; 8(3):543-50. PMID: 303161.
    Citations: 10     Fields:    Translation:HumansCells
  84. Einstein LP, Hansen PJ, Ballow M, Davis AE, Davis JS, Alper CA, Rosen FS, Colten HR. Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3-deficient humans. J Clin Invest. 1977 Nov; 60(5):963-9. PMID: 332718; PMCID: PMC372447.
    Citations: 33     Fields:    Translation:HumansCells
  85. Davis AE, Ziegler JB, Gelfand EW, Rosen FS, Alper CA. Heterogeneity of nephritic factor and its identification as an immunoglobulin. Proc Natl Acad Sci U S A. 1977 Sep; 74(9):3980-3. PMID: 269447; PMCID: PMC431810.
    Citations: 23     Fields:    Translation:Humans
  86. Davis AE, Arnaout MA, Alper CA, Rosen FS. Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG? N Engl J Med. 1977 Jul 21; 297(3):144-5. PMID: 865586.
    Citations: 6     Fields:    Translation:Humans
  87. Alper CA, Davis AE, Rosen FS. Complement and immunologic disease. Arthritis Rheum. 1977 Mar; 20(2 Suppl):449-58. PMID: 263919.
    Citations: 1     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Davis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (424)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.